DNA test aims to predict painful side effects of prostate cancer radiation
NCT ID NCT04624256
Summary
This study is testing whether a genetic test can predict which prostate cancer patients are at high or low risk for serious urinary and bowel side effects from a specific type of radiation therapy. About 208 men with early-stage prostate cancer will take the test, and then discuss with their doctor which radiation treatment plan to follow. The goal is to see if having this genetic information helps patients and doctors make better treatment choices to avoid severe side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.